pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3911 |
Genomic Coordinates | chr9: 127690687 - 127690795 |
Description | Homo sapiens miR-3911 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3911 | |||||||||||||||||||||||||||
Sequence | 12| UGUGUGGAUCCUGGAGGAGGCA |33 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | DPYSL5 | ||||||||||||||||||||
Synonyms | CRAM, CRMP-5, CRMP5, Ulip6 | ||||||||||||||||||||
Description | dihydropyrimidinase like 5 | ||||||||||||||||||||
Transcript | NM_020134 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on DPYSL5 | |||||||||||||||||||||
3'UTR of DPYSL5 (miRNA target sites are highlighted) |
>DPYSL5|NM_020134|3'UTR 1 AGGCATTGCCAAGCCCCCCGAGTGAGGACGCACCGCCGCCACCAGCCCGCAACTCTCCAGCCGAAGCTGCAGGGGCAGGA 81 GAGGCTGGGCTGGGTGGCACACCACCCGAGGGGGGCCCCGGGACCCACGGAGCCCTCCCTATGTCTGCAAAGTGATTCAC 161 TGTGCTTCGAGCCAACTCTAACAGGCACTTTGAGATGTGTTCCTCCTGCTGTAGTCCTTTCTGCCTTGGCCTCGGCGGGC 241 TTTTCTGGGGCCCAGGAAGCCCACACTATGCACAGAGCCCAATGCATAGAGCCCTGGCCAGCCCTTCCTCTCACTCCTGC 321 CTCCGCTGGCTTTGGGAAAGCCCAGACTTTAGTGCCCTGCCCCCTGGCTGACTGGCCAGTTGCCCAGAGCACTTTAGCAG 401 ATGTGGTTTCAAAGTAAAGGCCTCCTCCCCCACCCCTTAGGCCCCGTGGTGACATTTCCCAAGTCAGACAGATGTCAGCT 481 TCCCAGCCATGCCCAGGACGTCCTATCTCCCCCAACCCACCTCTGGCCCTGTGTAGGGGCAGGGATGGGGGTGGCTGGGA 561 CTCCTGGTGCCCCTCGCCAGCTTCTCCTGCGCCCCGCCCACACCCTCGGGGGGTCACAGGCCCAGAAGGGTAGCTGGGCG 641 GGGCTCGAGGCTGGTGCCAGGCGCGTGTAAATGGTTTTGTTTTGCACGTTTGGTTTGCGCAGTAGTTTGGTTTGACTTGT 721 TTGTGCATCCTGTGAAAAATAACGGTGCTTGTGTCACTAGCATAGAATAGCGACAGGAATAGATGTGGTCCTTAGGAGAC 801 GCTGCACTTGACACCAACCAGACAGCACAGGGCAGGGGTGGTGGAGGGGGCTGGGCTCACAGGCCTCTCTTTTCCCCGCC 881 TGCAGTCTTCTGGGCTGCGGGAGGCCCTGGCCCTTTCCCCTTCCCCTCCCCTCCTTGTCTAGTTTCCCACATTCCAAAAG 961 GGGGCCTGGGATGCTAGCCCCAGAGATGCCAGCCCTTCAGGAAGCAGGTGTCCTTTCCCCTCTCTGCCCCTGATCACTCC 1041 CAGCACTCCCCTTGCCTTCCCCTGTCTTCACCTGCCACCACACACACACACACACACACACACACACACACACACGCACG 1121 GCTTCCTATAACTTCTTCCTGCTGGACAGAGACTCAGCGCTCCTCCTGTGTGACTGGCAAGAGGCCTCATGCCTGCTGAG 1201 AGAGGAGGAGTGGGAGAGGGGCTTGCCAGACACCAGAGAGGGAGACCCCAGGCCCACAGGACCTGGCTGTCGAACCCGCA 1281 TTGCTGCTCAGGTGCCGTGATCTCCCGTGGTCGGCACCAGGCCCTTGCCAGCTCATGGCCTCATCTTCTCCCCTGTCCAT 1361 CCAGGTGGGCCCTCCCTGCTTCTAAAGCCCCACAGAAGTTCCCATGGAAACACTAGAGGCCGGGTGTCTCCTTCCACCTC 1441 CAGTGATCTGGGAAGTGACCCAGCCGCCTGCCCTTGTTAAGCCTGGTCTGCCCCGTGGGAAGTGACTTCATGTTGCACAT 1521 GTGATTTCAGCCCCCGAGGCTTGCGCGAGGCTTCTGGACCCTCGGTTAAAGGTCAGCCCCTGGCCGGGTGCGGTGGCTCA 1601 CGCCTGTAATCCCAGCACTTTGGGAGGCCAAGGCGGGTGGATCATGGAGTCAGGAGATCGAGACCATCCTGGCTAACACG 1681 GTGAAACCCCGTCTCTACTAAAAATACAAAAATTACCCAGGCGTGGTGGCGGGCGCCTGTAGTCCCAGCTACTGAGGAGG 1761 CTGAGGCAGGAGAATAGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCACGCCACTGCACTTCAGCCTGGAC 1841 GACAGAGTGAGACTCCATCTCAAAAAACAGACAAACAAAAAAGTCAGCCCCTGCACATCTCTGTAGTGCTTTTCATGTAT 1921 TCAAACCACTTCCGTATATGACCTCTCACTTAGTCCTCATGACAATGGAGCACTTATTATTCTTCCCATTTTACAGATGA 2001 GGAAACTAAGACCCAGAAAGTTCAGGTCCTCTGACCCCAGAAGTGTCTGTGATGACCCTCCCAACCTTGGCTATCTACCC 2081 CACCTGTGGAGAGGAGGTCTGGGGTGACATCTATTGTAGATCCCACCTGAGAGTTTAACCAATGAGAAGACTTACTTTCC 2161 TGGTAGGCAGCCTGCTTTGTTTTGCACAGGAAGATAGATTTTTTTTCTCATCTTTCTTATAAACAACCTCATGCACATTC 2241 TGTGTTTGAGCCAAGACTAGTCACCCATTGGGGGCTAACCGTGCAGTGTGAGCTGCGTCCACACCCTCACTTCTCCCTTC 2321 ACTCCCCCTTTCCTCACTCAGGGGCTGAGAGGACAGAGGTGGTCAGCCGGGGAGCAGAGGTGGCGAAGGGGCTCATGGCA 2401 AGTGGCAGCCATTGGAACAGGGGTGAGGACCCAGGCCTGGGAAAGCCACCAGGGATGGGGGAAACCATGACGCCGCCTCC 2481 TGGTGCAGTGCACACCATCTCTATCCCTGTCAGCCCTCACTGGGTCATGGGCCTTGGGCAGATGTCAAAGAGCCCAGCAG 2561 CAGCGGTGGTGGCCAGCTGGGCAGAGCATCCTTGCTTGGGCTAGGAAAGCTTTACCTTCTCTGAGTGCCTCCGCCTGAGA 2641 GATGTGTGACCCGTGGCACCAGGGAACCACGTCTTGGAGTGGTCCACTGTAGGCCATGCGCTTCATCCACCCCCAGTCCC 2721 TACATAGGCCCTACCCTTGCCCGGGAGCTTCTAGATAGAAATCAGAAAGAGATTCAAGGAGCCAAATGAGCGGTCAGCCC 2801 CCACCATGCACTCCTTGCCCCGTGCAGAGCTCCAGCCAGCTTCGTCACCAGCCCCACTGGCTCCTGGTTGGAACGAAAGG 2881 GTCTCTGGTTGCACTGAATGCAGCTCTCAAACTGGTCTTGTACTTGCTGAATAAATACTGTTGTTCTTGCCTTAGCTGCT 2961 CTCTAGGTTTGTGGGGTTAAGTTGCCAGAAAATTGTGCTACTGTGTGTGCGTGTGCGTGCGTGTGTGTAGTGCTAGGAGT 3041 CCACAGTAGGTCTCTGTCAAGCCGATGTCGTGATGAGGGCTTTTCTGATACTGACCCAGAAGCCACAGAACCACAAGGAA 3121 ACCCAAACCCCCTCCAGCTGCTGAGGCGCAGGCACAGCCTGGGGTCGGATGGAGCCTCCAGCACCCCAGCACCCAGGTGA 3201 CTTCCCCACTCCCCTGTAAATGTCATGGTGCTAAGACTGTGTCAACCCCAAGACGACACATGGTCCTGTGCTTTGGCCAC 3281 CGTTTGAGGCAAAAACTAAACAGCCCGACACGTTGTGTTCTGGTGCAGGTTTGTATTAAACTGTAGCTACTTCTCAAAAA 3361 AAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | BT474 | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1395166. RNA binding protein: AGO. Condition:BT474 AGO HITS-CLIP Replicate 1
... - Pillai MM; Gillen AE; Yamamoto TM; Kline E; et al., 2014, Breast cancer research and treatment. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Pillai MM; Gillen AE; Yamamoto TM; Kline E; et al. - Breast cancer research and treatment, 2014
miRNAs regulate the expression of genes in both normal physiology and disease. While miRNAs have been demonstrated to play a pivotal role in aspects of cancer biology, these reports have generally focused on the regulation of single genes. Such single-gene approaches have significant limitations, relying on miRNA expression levels and heuristic predictions of mRNA-binding sites. This results in only circumstantial evidence of miRNA-target interaction and typically leads to large numbers of false positive predictions. Here, we used a genome-wide approach (high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation, HITS-CLIP) to define direct miRNA-mRNA interactions in three breast cancer subtypes (estrogen receptor positive, Her2 amplified, and triple negative). Focusing on steroid receptor signaling, we identified two novel regulators of the ER pathway (miR-9-5p and miR-193a/b-3p), which together target multiple genes involved in ER signaling. Moreover, this approach enabled the definition of miR-9-5p as a global regulator of steroid receptor signaling in breast cancer. We show that miRNA targets and networks defined by HITS-CLIP under physiologic conditions are predictive of patient outcomes and provide global insight into miRNA regulation in breast cancer.
LinkOut: [PMID: 24906430]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Cardiac Tissues |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM2202479. RNA binding protein: AGO2. Condition:S4_LV_29yo_Male_AGO2_bound_RNA
HITS-CLIP data was present in GSM2202478. RNA binding protein: AGO2. Condition:S3_LV_36yo_Male_AGO2_bound_RNA
... - Spengler RM; Zhang X; Cheng C; McLendon JM; et al., 2016, Nucleic acids research. |
Article |
Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP.
- Spengler RM; Zhang X; Cheng C; McLendon JM; et al.- Nucleic acids research, 2016
MicroRNAs (miRs) have emerged as key biological effectors in human health and disease. These small noncoding RNAs are incorporated into Argonaute (Ago) proteins, where they direct post-transcriptional gene silencing via base-pairing with target transcripts. Although miRs have become intriguing biological entities and attractive therapeutic targets, the translational impacts of miR research remain limited by a paucity of empirical miR targeting data, particularly in human primary tissues. Here, to improve our understanding of the diverse roles miRs play in cardiovascular function and disease, we applied high-throughput methods to globally profile miR:target interactions in human heart tissues. We deciphered Ago2:RNA interactions using crosslinking immunoprecipitation coupled with high-throughput sequencing (HITS-CLIP) to generate the first transcriptome-wide map of miR targeting events in human myocardium, detecting 4000 cardiac Ago2 binding sites across >2200 target transcripts. Our initial exploration of this interactome revealed an abundance of miR target sites in gene coding regions, including several sites pointing to new miR-29 functions in regulating cardiomyocyte calcium, growth and metabolism. Also, we uncovered several clinically-relevant interactions involving common genetic variants that alter miR targeting events in cardiomyopathy-associated genes. Overall, these data provide a critical resource for bolstering translational miR research in heart, and likely beyond.
LinkOut: [PMID: 27418678]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_020134 | 3UTR | ACACACACACACACACACACACACACACACACGCACGGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_020134 | 3UTR | ACACACACACACACACACACACACACACACACACGCACGGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_020134 | 3UTR | ACACACACACACACACACACACACACACACACACGCACGGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1395166 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | BT474 / BT474 AGO HITS-CLIP Replicate 1 |
Location of target site | ENST00000288699.6 | 3UTR | CACCACACACACACACACACACACACACACACACACACAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24906430 / GSE57855 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000288699.6 | 3UTR | UCUUCACCUGCCACCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
70 hsa-miR-3911 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT207399 | MAT2A | methionine adenosyltransferase 2A | 2 | 6 | ||||||||
MIRT284537 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | 2 | 2 | ||||||||
MIRT291946 | TPM4 | tropomyosin 4 | 2 | 2 | ||||||||
MIRT293609 | PVR | poliovirus receptor | 2 | 2 | ||||||||
MIRT357688 | PAIP2 | poly(A) binding protein interacting protein 2 | 2 | 2 | ||||||||
MIRT451607 | MEIS3P1 | Meis homeobox 3 pseudogene 1 | 2 | 2 | ||||||||
MIRT452110 | IFITM1 | interferon induced transmembrane protein 1 | 2 | 2 | ||||||||
MIRT457804 | KLHL25 | kelch like family member 25 | 2 | 2 | ||||||||
MIRT462730 | EFNB1 | ephrin B1 | 2 | 2 | ||||||||
MIRT463219 | ZNF131 | zinc finger protein 131 | 2 | 2 | ||||||||
MIRT464141 | VPS28 | VPS28, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT467582 | SLC7A5 | solute carrier family 7 member 5 | 2 | 6 | ||||||||
MIRT470824 | PLXND1 | plexin D1 | 2 | 2 | ||||||||
MIRT474230 | LCLAT1 | lysocardiolipin acyltransferase 1 | 2 | 2 | ||||||||
MIRT478989 | COLGALT1 | collagen beta(1-O)galactosyltransferase 1 | 2 | 2 | ||||||||
MIRT479462 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT483558 | SYT2 | synaptotagmin 2 | 2 | 2 | ||||||||
MIRT484483 | SLC9A1 | solute carrier family 9 member A1 | 2 | 2 | ||||||||
MIRT485224 | PRICKLE1 | prickle planar cell polarity protein 1 | 2 | 2 | ||||||||
MIRT490356 | DPYSL5 | dihydropyrimidinase like 5 | 2 | 4 | ||||||||
MIRT493177 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT509802 | CHAF1B | chromatin assembly factor 1 subunit B | 2 | 4 | ||||||||
MIRT511815 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT512254 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 6 | ||||||||
MIRT513025 | GPT2 | glutamic--pyruvic transaminase 2 | 2 | 2 | ||||||||
MIRT519640 | ZNF772 | zinc finger protein 772 | 2 | 4 | ||||||||
MIRT531178 | SIGLEC12 | sialic acid binding Ig like lectin 12 (gene/pseudogene) | 2 | 2 | ||||||||
MIRT537870 | EDA2R | ectodysplasin A2 receptor | 2 | 2 | ||||||||
MIRT551914 | IGLON5 | IgLON family member 5 | 2 | 2 | ||||||||
MIRT558359 | DMTF1 | cyclin D binding myb like transcription factor 1 | 2 | 2 | ||||||||
MIRT559771 | URGCP-MRPS24 | URGCP-MRPS24 readthrough | 2 | 4 | ||||||||
MIRT559813 | ZNF83 | zinc finger protein 83 | 2 | 2 | ||||||||
MIRT561999 | LPP | LIM domain containing preferred translocation partner in lipoma | 2 | 2 | ||||||||
MIRT565754 | SERTAD2 | SERTA domain containing 2 | 2 | 2 | ||||||||
MIRT569423 | DCAF8 | DDB1 and CUL4 associated factor 8 | 2 | 2 | ||||||||
MIRT569845 | RGS5 | regulator of G protein signaling 5 | 2 | 2 | ||||||||
MIRT606928 | CDK15 | cyclin dependent kinase 15 | 2 | 2 | ||||||||
MIRT607616 | TMEM130 | transmembrane protein 130 | 2 | 4 | ||||||||
MIRT607629 | TRIOBP | TRIO and F-actin binding protein | 2 | 2 | ||||||||
MIRT607885 | SATB1 | SATB homeobox 1 | 2 | 2 | ||||||||
MIRT607942 | SSX2 | SSX family member 2 | 2 | 4 | ||||||||
MIRT608017 | CARNS1 | carnosine synthase 1 | 2 | 4 | ||||||||
MIRT608036 | UBLCP1 | ubiquitin like domain containing CTD phosphatase 1 | 2 | 2 | ||||||||
MIRT608063 | SSX2B | SSX family member 2B | 2 | 4 | ||||||||
MIRT608558 | SBK1 | SH3 domain binding kinase 1 | 2 | 6 | ||||||||
MIRT608915 | NCDN | neurochondrin | 2 | 6 | ||||||||
MIRT615876 | HIF1AN | hypoxia inducible factor 1 alpha subunit inhibitor | 2 | 4 | ||||||||
MIRT618023 | ELFN1 | extracellular leucine rich repeat and fibronectin type III domain containing 1 | 2 | 2 | ||||||||
MIRT620505 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 2 | 2 | ||||||||
MIRT628101 | IL1RAPL1 | interleukin 1 receptor accessory protein like 1 | 2 | 2 | ||||||||
MIRT628700 | ZNF548 | zinc finger protein 548 | 2 | 2 | ||||||||
MIRT630658 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT643508 | ZNF28 | zinc finger protein 28 | 2 | 2 | ||||||||
MIRT646379 | SLC22A6 | solute carrier family 22 member 6 | 2 | 2 | ||||||||
MIRT660041 | C15orf61 | chromosome 15 open reading frame 61 | 2 | 2 | ||||||||
MIRT687700 | KRR1 | KRR1, small subunit processome component homolog | 2 | 2 | ||||||||
MIRT688858 | CAMKK2 | calcium/calmodulin dependent protein kinase kinase 2 | 2 | 2 | ||||||||
MIRT690443 | REPIN1 | replication initiator 1 | 2 | 2 | ||||||||
MIRT690456 | ZNF33A | zinc finger protein 33A | 2 | 2 | ||||||||
MIRT693796 | RHOG | ras homolog family member G | 2 | 2 | ||||||||
MIRT694274 | ZNF529 | zinc finger protein 529 | 2 | 4 | ||||||||
MIRT697697 | WAC | WW domain containing adaptor with coiled-coil | 2 | 2 | ||||||||
MIRT700242 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT701836 | MRPL37 | mitochondrial ribosomal protein L37 | 2 | 2 | ||||||||
MIRT704255 | DHCR24 | 24-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT707203 | SDK2 | sidekick cell adhesion molecule 2 | 2 | 2 | ||||||||
MIRT710365 | CREB5 | cAMP responsive element binding protein 5 | 2 | 2 | ||||||||
MIRT711943 | WDFY1 | WD repeat and FYVE domain containing 1 | 2 | 2 | ||||||||
MIRT715496 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT719250 | MS4A1 | membrane spanning 4-domains A1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|